In vivo validation of peptidoglycan recycling as target to disable AmpC-mediated resistance and reduce virulence enhancing the cell-wall-targeting immunity
In vivo validation of peptidoglycan recycling as target to disable AmpC-mediated resistance and reduce virulence enhancing the cell-wall-targeting immunity
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation